Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B

NCT07231276 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

113

Enrollment

OTHER

Sponsor class

Conditions

HBV
Chronic Hepatitis B Virus

Interventions

DRUG: Peginterferon alfa-2b Injection

Sponsor

Nanfang Hospital, Southern Medical University